Table 3. Correlation between the IBACS and comparator instruments at baseline and follow-up.
Baseline | Follow-up | n* | |
---|---|---|---|
Symptom Checklist 90-Revised (SCL-90-R) | |||
SCL-90-R global severity index | .48** | 0.61** | 61 |
SCL-90-R somatization | 0.29* | 0.52** | 55 |
SCL-90-R obsessive compulsive | 0.44** | 0.66** | 59 |
SCL-90-R interpersonal sensitivity | 0.38** | 0.52** | 60 |
SCL-90-R depression | 0.41** | 0.58** | 51 |
SCL-90-R anxiety | 0.46** | 0.63** | 54 |
SCL-90-R hostility | 0.22 | 0.40** | 62 |
SCL-90-R phobic anxiety | 0.44** | 0.52** | 60 |
SCL-90-R paranoid ideation | 0.49** | 0.58** | 60 |
SCL-90-R psychoticism | 0.54** | 0.62** | 57 |
Inventory of Complicated Grief-Revised | .82** | .71** | 55 |
Impact of Event Scale- Revised (IES-R) | |||
IES-R sum | .34** | .57** | 65 |
IES-R avoidance | 0.16 | .43** | 65 |
IES-R hyper-arousal | .40** | .59** | 65 |
IES-R intrusive thoughts | .35** | .56** | 65 |
Clinical Outcomes in Routine Evaluation-Revised (CORE) | |||
CORE Sum | .71** | .68** | 50 |
CORE functioning | .35** | .40** | 58 |
CORE problems | .60** | .56** | 57 |
CORE risk | .64** | .56** | 61 |
CORE well-being | .32** | .27* | 63 |
*Sample sizes vary due to listwise deletion
**p < .01